Pre-order Enquiry
Request Free Sample
Global and United States CAR T-Cell Therapy Market Report & Forecast 2022-2028
SKU ID : QYR-20737756 | Publishing Date : 18-Apr-2022 | No. of pages : 103
Detailed TOC of Global and United States CAR T-Cell Therapy Market Report & Forecast 2022-2028
1 Study Coverage1.1 CAR T-Cell Therapy Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Introduction
1.2 Global CAR T-Cell Therapy Outlook 2017 VS 2022 VS 2028
1.2.1 Global CAR T-Cell Therapy Market Size for the Year 2017-2028
1.2.2 Global CAR T-Cell Therapy Market Size for the Year 2017-2028
1.3 CAR T-Cell Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States CAR T-Cell Therapy in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of CAR T-Cell Therapy Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 CAR T-Cell Therapy Market Dynamics
1.4.1 CAR T-Cell Therapy Industry Trends
1.4.2 CAR T-Cell Therapy Market Drivers
1.4.3 CAR T-Cell Therapy Market Challenges
1.4.4 CAR T-Cell Therapy Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 CAR T-Cell Therapy by Type
2.1 CAR T-Cell Therapy Market Segment by Type
2.1.1 Allogeneic
2.1.2 Autologous
2.2 Global CAR T-Cell Therapy Market Size by Type (2017, 2022 & 2028)
2.3 Global CAR T-Cell Therapy Market Size by Type (2017-2028)
2.4 United States CAR T-Cell Therapy Market Size by Type (2017, 2022 & 2028)
2.5 United States CAR T-Cell Therapy Market Size by Type (2017-2028)
3 CAR T-Cell Therapy by Application
3.1 CAR T-Cell Therapy Market Segment by Application
3.1.1 Hospitals
3.1.2 Cancer Research Centers
3.1.3 Others
3.2 Global CAR T-Cell Therapy Market Size by Application (2017, 2022 & 2028)
3.3 Global CAR T-Cell Therapy Market Size by Application (2017-2028)
3.4 United States CAR T-Cell Therapy Market Size by Application (2017, 2022 & 2028)
3.5 United States CAR T-Cell Therapy Market Size by Application (2017-2028)
4 Global CAR T-Cell Therapy Competitor Landscape by Company
4.1 Global CAR T-Cell Therapy Market Size by Company
4.1.1 Top Global CAR T-Cell Therapy Companies Ranked by Revenue (2021)
4.1.2 Global CAR T-Cell Therapy Revenue by Player (2017-2022)
4.2 Global CAR T-Cell Therapy Concentration Ratio (CR)
4.2.1 CAR T-Cell Therapy Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of CAR T-Cell Therapy in 2021
4.2.3 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global CAR T-Cell Therapy Headquarters, Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Type
4.3.1 Global CAR T-Cell Therapy Headquarters and Area Served
4.3.2 Global CAR T-Cell Therapy Companies Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into CAR T-Cell Therapy Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States CAR T-Cell Therapy Market Size by Company
4.5.1 Top CAR T-Cell Therapy Players in United States, Ranked by Revenue (2021)
4.5.2 United States CAR T-Cell Therapy Revenue by Players (2020, 2021 & 2022)
5 Global CAR T-Cell Therapy Market Size by Region
5.1 Global CAR T-Cell Therapy Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global CAR T-Cell Therapy Market Size by Region (2017-2028)
5.2.1 Global CAR T-Cell Therapy Market Size by Region: 2017-2022
5.2.2 Global CAR T-Cell Therapy Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.1.2 North America CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific CAR T-Cell Therapy Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.3.2 Europe CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.4.2 Latin America CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa CAR T-Cell Therapy Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa CAR T-Cell Therapy Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Celgene (Juno Therapeutics)
7.1.1 Celgene (Juno Therapeutics) Company Details
7.1.2 Celgene (Juno Therapeutics) Business Overview
7.1.3 Celgene (Juno Therapeutics) CAR T-Cell Therapy Introduction
7.1.4 Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2017-2022)
7.1.5 Celgene (Juno Therapeutics) Recent Development
7.2 Novartis
7.2.1 Novartis Company Details
7.2.2 Novartis Business Overview
7.2.3 Novartis CAR T-Cell Therapy Introduction
7.2.4 Novartis Revenue in CAR T-Cell Therapy Business (2017-2022)
7.2.5 Novartis Recent Development
7.3 Gilead (Kite Pharma)
7.3.1 Gilead (Kite Pharma) Company Details
7.3.2 Gilead (Kite Pharma) Business Overview
7.3.3 Gilead (Kite Pharma) CAR T-Cell Therapy Introduction
7.3.4 Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2017-2022)
7.3.5 Gilead (Kite Pharma) Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Details
7.4.2 Pfizer Business Overview
7.4.3 Pfizer CAR T-Cell Therapy Introduction
7.4.4 Pfizer Revenue in CAR T-Cell Therapy Business (2017-2022)
7.4.5 Pfizer Recent Development
7.5 CARsgen Therapeutics
7.5.1 CARsgen Therapeutics Company Details
7.5.2 CARsgen Therapeutics Business Overview
7.5.3 CARsgen Therapeutics CAR T-Cell Therapy Introduction
7.5.4 CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
7.5.5 CARsgen Therapeutics Recent Development
7.6 Autolus Therapeutics
7.6.1 Autolus Therapeutics Company Details
7.6.2 Autolus Therapeutics Business Overview
7.6.3 Autolus Therapeutics CAR T-Cell Therapy Introduction
7.6.4 Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
7.6.5 Autolus Therapeutics Recent Development
7.7 Aurora BioPharma
7.7.1 Aurora BioPharma Company Details
7.7.2 Aurora BioPharma Business Overview
7.7.3 Aurora BioPharma CAR T-Cell Therapy Introduction
7.7.4 Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2017-2022)
7.7.5 Aurora BioPharma Recent Development
7.8 Sorrento Therapeutics
7.8.1 Sorrento Therapeutics Company Details
7.8.2 Sorrento Therapeutics Business Overview
7.8.3 Sorrento Therapeutics CAR T-Cell Therapy Introduction
7.8.4 Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
7.8.5 Sorrento Therapeutics Recent Development
7.9 Mustang Bio
7.9.1 Mustang Bio Company Details
7.9.2 Mustang Bio Business Overview
7.9.3 Mustang Bio CAR T-Cell Therapy Introduction
7.9.4 Mustang Bio Revenue in CAR T-Cell Therapy Business (2017-2022)
7.9.5 Mustang Bio Recent Development
7.10 Bluebird Bio
7.10.1 Bluebird Bio Company Details
7.10.2 Bluebird Bio Business Overview
7.10.3 Bluebird Bio CAR T-Cell Therapy Introduction
7.10.4 Bluebird Bio Revenue in CAR T-Cell Therapy Business (2017-2022)
7.10.5 Bluebird Bio Recent Development
7.11 Collectis
7.11.1 Collectis Company Details
7.11.2 Collectis Business Overview
7.11.3 Collectis CAR T-Cell Therapy Introduction
7.11.4 Collectis Revenue in CAR T-Cell Therapy Business (2017-2022)
7.11.5 Collectis Recent Development
7.12 Allogene Therapeutics
7.12.1 Allogene Therapeutics Company Details
7.12.2 Allogene Therapeutics Business Overview
7.12.3 Allogene Therapeutics CAR T-Cell Therapy Introduction
7.12.4 Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
7.12.5 Allogene Therapeutics Recent Development
7.13 Celyad
7.13.1 Celyad Company Details
7.13.2 Celyad Business Overview
7.13.3 Celyad CAR T-Cell Therapy Introduction
7.13.4 Celyad Revenue in CAR T-Cell Therapy Business (2017-2022)
7.13.5 Celyad Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States CAR T-Cell Therapy Market Report & Forecast 2022-2028
List of TablesTable 1. CAR T-Cell Therapy Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. CAR T-Cell Therapy Market Trends
Table 3. CAR T-Cell Therapy Market Drivers
Table 4. CAR T-Cell Therapy Market Challenges
Table 5. CAR T-Cell Therapy Market Restraints
Table 6. Global CAR T-Cell Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States CAR T-Cell Therapy Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global CAR T-Cell Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States CAR T-Cell Therapy Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top CAR T-Cell Therapy Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global CAR T-Cell Therapy Revenue by Player, (US$ Million), 2017-2022
Table 12. Global CAR T-Cell Therapy Revenue Share by Player, 2017-2022
Table 13. Global CAR T-Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global CAR T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2021)
Table 15. Top Players of CAR T-Cell Therapy in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into CAR T-Cell Therapy Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top CAR T-Cell Therapy Players in United States Market, Ranking by Revenue (2021)
Table 20. United States CAR T-Cell Therapy Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States CAR T-Cell Therapy Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global CAR T-Cell Therapy Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global CAR T-Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global CAR T-Cell Therapy Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific CAR T-Cell Therapy Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa CAR T-Cell Therapy Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Celgene (Juno Therapeutics) Company Details
Table 31. Celgene (Juno Therapeutics) Business Overview
Table 32. Celgene (Juno Therapeutics) CAR T-Cell Therapy Product
Table 33. Celgene (Juno Therapeutics) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 34. Celgene (Juno Therapeutics) Recent Development
Table 35. Novartis Company Details
Table 36. Novartis Business Overview
Table 37. Novartis CAR T-Cell Therapy Product
Table 38. Novartis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 39. Novartis Recent Development
Table 40. Gilead (Kite Pharma) Company Details
Table 41. Gilead (Kite Pharma) Business Overview
Table 42. Gilead (Kite Pharma) CAR T-Cell Therapy Product
Table 43. Gilead (Kite Pharma) Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 44. Gilead (Kite Pharma) Recent Development
Table 45. Pfizer Company Details
Table 46. Pfizer Business Overview
Table 47. Pfizer CAR T-Cell Therapy Product
Table 48. Pfizer Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 49. Pfizer Recent Development
Table 50. CARsgen Therapeutics Company Details
Table 51. CARsgen Therapeutics Business Overview
Table 52. CARsgen Therapeutics CAR T-Cell Therapy Product
Table 53. CARsgen Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 54. CARsgen Therapeutics Recent Development
Table 55. Autolus Therapeutics Company Details
Table 56. Autolus Therapeutics Business Overview
Table 57. Autolus Therapeutics CAR T-Cell Therapy Product
Table 58. Autolus Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 59. Autolus Therapeutics Recent Development
Table 60. Aurora BioPharma Company Details
Table 61. Aurora BioPharma Business Overview
Table 62. Aurora BioPharma CAR T-Cell Therapy Product
Table 63. Aurora BioPharma Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 64. Aurora BioPharma Recent Development
Table 65. Sorrento Therapeutics Company Details
Table 66. Sorrento Therapeutics Business Overview
Table 67. Sorrento Therapeutics CAR T-Cell Therapy Product
Table 68. Sorrento Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 69. Sorrento Therapeutics Recent Development
Table 70. Mustang Bio Company Details
Table 71. Mustang Bio Business Overview
Table 72. Mustang Bio CAR T-Cell Therapy Product
Table 73. Mustang Bio Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 74. Mustang Bio Recent Development
Table 75. Bluebird Bio Company Details
Table 76. Bluebird Bio Business Overview
Table 77. Bluebird Bio CAR T-Cell Therapy Product
Table 78. Bluebird Bio Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 79. Bluebird Bio Recent Development
Table 80. Collectis Company Details
Table 81. Collectis Business Overview
Table 82. Collectis CAR T-Cell Therapy Product
Table 83. Collectis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 84. Collectis Recent Development
Table 85. Allogene Therapeutics Company Details
Table 86. Allogene Therapeutics Business Overview
Table 87. Allogene Therapeutics CAR T-Cell Therapy Product
Table 88. Allogene Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 89. Allogene Therapeutics Recent Development
Table 90. Celyad Company Details
Table 91. Celyad Business Overview
Table 92. Celyad CAR T-Cell Therapy Product
Table 93. Celyad Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
Table 94. Celyad Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. CAR T-Cell Therapy Product Picture
Figure 2. Global CAR T-Cell Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global CAR T-Cell Therapy Market Size 2017-2028 (US$ Million)
Figure 4. United States CAR T-Cell Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States CAR T-Cell Therapy Market Size 2017-2028 (US$ Million)
Figure 6. United States CAR T-Cell Therapy Market Share in Global 2017-2028
Figure 7. CAR T-Cell Therapy Report Years Considered
Figure 8. Product Picture of Allogeneic
Figure 9. Product Picture of Autologous
Figure 10. Global CAR T-Cell Therapy Market Share by Type in 2022 & 2028
Figure 11. Global CAR T-Cell Therapy Market Size by Type (2017-2028) & (US$ Million)
Figure 12. Global CAR T-Cell Therapy Market Share by Type (2017-2028)
Figure 13. United States CAR T-Cell Therapy Market Share by Type in 2022 & 2028
Figure 14. United States CAR T-Cell Therapy Market Size by Type (2017-2028) & (US$ Million)
Figure 15. United States CAR T-Cell Therapy Market Share by Type (2017-2028)
Figure 16. Product Picture of Hospitals
Figure 17. Product Picture of Cancer Research Centers
Figure 18. Product Picture of Others
Figure 19. Global CAR T-Cell Therapy Market Share by Application in 2022 & 2028
Figure 20. Global CAR T-Cell Therapy Market Size by Application (2017-2028) & (US$ Million)
Figure 21. Global CAR T-Cell Therapy Market Share by Application (2017-2028)
Figure 22. United States CAR T-Cell Therapy Market Share by Application in 2022 & 2028
Figure 23. United States CAR T-Cell Therapy Market Size by Application (2017-2028) & (US$ Million)
Figure 24. United States CAR T-Cell Therapy Market Share by Application (2017-2028)
Figure 25. North America CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 26. U.S. CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 27. Canada CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Europe CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 29. Germany CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 30. France CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. U.K. CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. Italy CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Russia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. China CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. Japan CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. South Korea CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. India CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Australia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Taiwan CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Indonesia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Thailand CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Malaysia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Philippines CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Latin America CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 46. Mexico CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Brazil CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Argentina CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate 2017-2028 (US$ Million)
Figure 50. Turkey CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. U.A.E CAR T-Cell Therapy Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Celgene (Juno Therapeutics) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 54. Novartis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 55. Gilead (Kite Pharma) Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 57. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 58. Autolus Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 59. Aurora BioPharma Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 60. Sorrento Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 61. Mustang Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 62. Bluebird Bio Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 63. Collectis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 64. Allogene Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 65. Celyad Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Keyplayers in Global and United States CAR T-Cell Therapy Market Report & Forecast 2022-2028
Celgene (Juno Therapeutics)Novartis
Gilead (Kite Pharma)
Pfizer
CARsgen Therapeutics
Autolus Therapeutics
Aurora BioPharma
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Collectis
Allogene Therapeutics
Celyad
Request Sample
Request Discount
